We also show the possibility that inhibiting MALAT1 may significantly diminish tumor size in animal models, thereby presenting novel diagnostic and treatment strategies for lung cancer in AAs and potentially mitigating racial disparities in lung cancer prognosis. Here, MALAT1 is linked to lung carcinoma.